FDA Issues Draft Guidance Aimed at Improving Diversity in Clinical Trials
- April 14, 2022
The Food and Drug Administration (FDA) issued April 13 new draft guidance for researchers on boosting enrollment of underrepresented racial and ethnic populations in clinical trials.
ARTICLE TAGS
You must be logged in to access this content.